SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-042401
Filing Date
2023-08-14
Accepted
2023-08-14 16:09:26
Documents
62
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q achv-20230630.htm   iXBRL 10-Q 2619577
2 EX-31.1 achv-ex31_1.htm EX-31.1 13378
3 EX-32.1 achv-ex32_1.htm EX-32.1 7881
4 GRAPHIC img226504927_0.jpg GRAPHIC 92506
  Complete submission text file 0000950170-23-042401.txt   8931756

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT achv-20230630.xsd EX-101.SCH 58316
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT achv-20230630_lab.xml EX-101.LAB 438762
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT achv-20230630_cal.xml EX-101.CAL 37926
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT achv-20230630_pre.xml EX-101.PRE 325567
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT achv-20230630_def.xml EX-101.DEF 245823
56 EXTRACTED XBRL INSTANCE DOCUMENT achv-20230630_htm.xml XML 1529566
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-80623 | Film No.: 231170081
SIC: 2835 In Vitro & In Vivo Diagnostic Substances